tbuckley/cabot-search huggingface dataset:
Childhood asthma and fruit consumption
Authors: B. J. Okoko, P. G. Burney, R. B. Newson, J. F. Potts, S. O. Shaheen
Journal: European Respiratory Journal (2007)

The present authors investigated whether wheezing is less common in children who consume more apples and other fruits. A population-based survey of 2,640 primary school children aged 5–10 yrs was carried out in Greenwich (South London, UK). Information about asthma symptoms and fruit consumption was obtained by means of a questionnaire. After controlling for potential confounding variables, eating bananas at least once a day (compared with less than once a month) was negatively associated with current wheeze (odds ratio 0.66; 95% confidence interval 0.44–1.00) and ever wheeze (0.69 (0.50–0.95)), but not with ever asthma (0.80 (0.56–1.14)). Drinking apple juice from concentrate at least once a day (compared with less than once a month) was also negatively associated with current wheeze (0.53 (0.34–0.83)), weakly associated with ever wheeze (0.74 (-0.54–1.02)), but not associated with ever asthma. Consumption of apples, other fruits and orange juice was not significantly associated with asthma symptoms. No association was found between eating fresh apples and asthma symptoms in the study population, but some evidence was found to suggest that a higher consumption of apple juice from concentrate and bananas may protect against wheezing in children.
Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource Settings
Authors: L. Kuhn, L. Denny, A. Pollack, A. Lorincz, R. M. Richart, T. C. Wright
Journal: JNCI Journal of the National Cancer Institute (2000)

In many low-resource settings, there are barriers to cytologic screening for cervical cancer. This study evaluates human papillomavirus (HPV) DNA testing as an alternative screening method.Cervical samples from 2944 previously unscreened South African women aged 35-65 years were tested for high-risk types of HPV with the use of the Hybrid Capture I (HCI) assay. Women also had a Pap smear, direct visual inspection of the cervix, and Cervicography(TM). Women positive on any screening test were referred for colposcopy. Samples from women with biopsy-confirmed, low-grade squamous intraepithelial lesions (SILs) (n = 95), high-grade SILs (n = 74), or invasive cervical cancer (n = 12) and a random sample of women with no cervical disease (n = 243) were retested for HPV DNA with the use of the more sensitive Hybrid Capture II (HCII) assay. All P values are two-sided.High-risk HPV DNA was detected in 73.3% and 88.4% of 86 women with high-grade SIL or invasive cancer and in 12.2% of 2680 and 18.1% of 243 women without evidence of cervical disease, with the use of the HCI and HCII assays, respectively. HPV DNA testing with the HCII assay was more sensitive than cytology for detecting high-grade SIL and invasive cancer (McNemar's test, P =.04), and testing with the HCI assay was of equivalent sensitivity (P =.61). Cytology had a statistically significantly better specificity (96.8%) than either the HCI assay (87.8%) or the HCII assay (81.9%) (P<.01). Receiver operating characteristic curves identified test cutoff values that allow HPV DNA testing to identify 57% of women with high-grade SIL or cancer, while classifying less than 5% of women with no cervical disease as HPV DNA positive.HPV DNA testing has a sensitivity equivalent to, or better than, that of cytology. Since HPV DNA testing programs may be easier to implement than cytologic screening, HPV testing should be considered for primary cervical cancer screening in low-resource settings.
Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).
Authors: G Delecoeuillerie, P Joly, A Cohen de Lara, J B Paolaggi
Journal: Annals of the Rheumatic Diseases (1988)

The treatment of polymyalgia rheumatica (PMR) and temporal arteritis (TA) is still controversial. To assess the influence on the course of these diseases of the clinical symptoms at initial presentation and of the starting dosage of corticosteroid (CS) treatment the data for 210 patients, who were diagnosed as having PMR or TA from 1976 to 1986 and were followed up closely, were reviewed. One hundred and thirty two patients were diagnosed as having 9clinically pure9 PMR; prednisone starting doses of over 15 mg daily provided more CS related adverse effects without any advantage. The mean duration of treatment was 25.7 months. Nine patients later developed symptoms of TA, and there were no predictive features for this. None experienced visual or neurological complications. Seventy eight patients were diagnosed as having clinical TA. Twenty five patients treated with low starting doses of prednisone, ranging from 10 to 20 mg/d (mean 16.2 mg/d), developed less CS related adverse effects and did not have more visual or neurological complications than 53 patients treated with higher doses. The mean duration of treatment was 30.9 months. Fifteen patients experienced visual or neurological complications and men (10/30) developed these complications more frequently than women (5/48) (p less than 0.02). These results suggest that (a) clinically pure PMR is a benign disease requiring low doses of CS treatment; (b) low doses of CS seem an adequate treatment for most cases of TA; (c) a worse prognosis seems attached to the male sex in TA.
Computer Analysis of the Orthogonal Electrocardiogram and Vectorcardiogram in Mitral Stenosis
Authors: ABE WALSTON, ALEXANDER HARLEY, HUBERT V. PIPBERGER
Journal: Circulation (1974)

Orthogonal electrocardiograms (Frank lead system) from 191 patients with pure mitral stenosis (MS) were compared to electrocardiograms from 510 normal patients and 296 patients with pulmonary emphysema (PE). All patients with MS underwent right heart catheterization; 121 patients underwent both left and right heart catheterization. Three hundred and thirty electrocardiographic measurements were obtained from each record and tested for their ability to distinguish mitral stenosis from normal. Two sets of diagnostic discriminators were selected: (1) ECG measurements which can be easily obtained by hand and (2) measurements which performed best in multivariate analysis using linear discriminant functions. The patients with mitral stenosis were separated into three hemodynamic subgroups according to mean pulmonary artery pressure (PAP) (0-30, 31-40, and &gt; 40 mm Hg). The ability of the selected measurements to recognize mitral stenosis increased as mean pulmonary artery pressure rose. The superiority of the multivariate technique, using nine measurements simultaneously, was readily demonstrated when compared to the hand measurements. At a constant level of 6% false positives, multivariate analysis allowed a 74% recognition rate of mitral stenosis compared to 44% with hand measurements.
Cigarette smoking, chronic peptic ulceration, and pepsin 1 secretion.
Authors: V Walker, W H Taylor
Journal: Gut (1979)

The relationship between the secretion of pepsin 1 (the most electronegative of the pepsins), and the smoking habits of 219 patients has been investigated. Significantly more cigarette smokers with peptic ulceration (72.5%) secreted pepsin 1 in greater than trace amounts after pentagastrin or histamine than did non-smokers with ulceration (51.2%). Differences of a similar order were found for men with duodenal ulcer, women with duodenal ulcer, and all patients with gastric ulcer, but the difference was statistically significant only for men with duodenal ulcer. Significantly more patients with peptic ulcer smoking six to 15 cigarettes/day secreted moderate or high concentrations of pepsin 1 than did heavier smokers or non-smokers. There was no significant association between cigarette smoking and pepsin 1 secretion among 74 patients without ulceration. Maximal acid output was not significantly related to smoking in any group studied. The findings add to the increasing body of evidence linking pepsins and pepsin 1 with the pathogenesis of peptic ulceration.
Follow up exercise studies in paediatric obesity: implications for long term effectiveness
Authors: M T Maziekas, L M LeMura, N M Stoddard, S Kaercher, T Martucci
Journal: British Journal of Sports Medicine (2003)

To examine the effects of exercise training on paediatric obesity immediately after training and at a one year follow up and to provide recommendations for future research.Studies that met the following criteria were included in a meta-analysis: (a) at least six subjects per group; (b) subject groups consisting of children in the 4-17 year age range; (c) pre-test and post-test values for body composition; (d) used exercise such as walking, jogging, cycle ergometry, high repetition resistance exercise, and combinations; (e) training programmes lasting eight weeks or more; (f) full length publications; (g) apparently healthy children.A total of 135 studies of exercise as a method of treatment of paediatric obesity were located. Eight, containing 236 subjects, met our criteria for inclusion. Across all designs and categories, fixed effects modelling yielded significant decreases in the dependent variable percentage body fat immediately (0=1.04 (0.35); 95% confidence interval (CI) 0.41 to 1.6) and one year after the exercise intervention (0=0.84 (0.51); 95% CI 0.22 to 0.94). Forward stepwise linear regression suggested that the percentage body fat measured at the end of exercise training, exercise duration, and programme length accounted for 53-86% of the variance for percentage body fat at one year.These data indicate that exercise is efficacious for reducing percentage body fat in obese children and adolescents, and that exercise intervention may encourage long term maintenance of the observed gains.
A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus.
Authors: C M Story, J E Mikulska, N E Simister
Journal: The Journal of Experimental Medicine (1994)

The acquisition of maternal antibodies is critical for immunologic defense of the newborn. In humans, maternal IgG is actively transported across the placenta. The receptor responsible for this transport has not been identified definitively. We report the isolation from a placental cDNA library of clones encoding the alpha-chain of an immunoglobulin G (IgG)-Fc receptor (hFcRn) that resembles a class I major histocompatibility complex antigen. The DNA and predicted amino acid sequences are very similar to those of the neonatal rat and mouse intestinal Fc receptors, rFcRn and mFcRn. These receptors mediate transport of maternal IgG from milk to the blood-stream of the suckling rat or mouse. Like rat and mouse FcRn, hFcRn binds IgG preferentially at low pH, which may imply that IgG binds hFcRn in an acidic intracellular compartment during transport across the placenta.
Further Evidence that the Pulmonary Capillary Venous Pressure Pulse in Man Reflects Cyclic Pressure Changes in the Left Atrium
Authors: LARS WERKÖ, E. VARNAUSKAS, H. ELIASCH, H. LAGERLÖF, A. SENNING, B. THOMASSON
Journal: Circulation Research (1953)

In four cases of atrial septal defect and in one case of mitral stenosis, the pressure pulse was recorded in the left atrium, in the first four cases through catheters, and in the fifth through a needle introduced through the chest wall. The pressure pulse was compared with pulmonary capillary pressure recorded simultaneously or nearly so. Good agreement was found both in shape and height of the two pressure pulses.
Epidemiology of knee injuries among adolescents: a systematic review
Authors: Q A Louw, J Manilall, K A Grimmer
Journal: British Journal of Sports Medicine (2007)

Youth sports injury is a public health concern, as it has detrimental effects on the health and well-being of young athletes. The knee joint is reported to be the most common joint injured by young sports participants. The potential loss of ability to participate in regular physical activity after injury is alarming, because physical inactivity is one of the major risk factors associated with systemic disease, disability and/or death worldwide.This paper presents a systematic review of the epidemiological research reporting on the prevalence of knee injuries among active adolescents to ascertain the global scope of the problem.The 19 eligible studies for this review were mostly (90%) conducted in developed countries. Global adolescent knee injury prevalence ranges between 10% and 25%, with more recent studies reporting higher percentages. The average methodological appraisal score of the 19 studies was 56%. Females and adolescents appear to be more at an increased risk of sustaining a knee injury compared with males.Developing standard injury definitions as well as descriptions of injury causes must be taken into consideration in future injury surveillance research in order to appropriately inform effective knee injury preventative programmes for youth.
Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease
Authors: I Peene
Journal: Annals of the Rheumatic Diseases (2002)

<b>Objective:</b> To determine whether anti-Ro52 is an independent serum marker in connective tissue disease. <b>Methods:</b> Over a two year period, 1727 consecutive antinuclear antibody (ANA) positive serum samples were analysed in parallel by double immunodiffusion with thymus/spleen nuclear extract and by line immunoassay with recombinant Ro52, recombinant La/SSB, and natural Ro60. Sera that were only reactive towards Ro52 were further analysed by a variety of additional anti-SSA/Ro detection methods and by specific anti-Ro52 and anti-Ro60 assays. Natural purified SSA/Ro was analysed by immunoblot and protein sequencing. <b>Results:</b> Analysis of natural purified SSA/Ro (Immunovision, Springdale, AR) showed only Ro60 and no immunoreactive Ro52. Consequently, assays based on this substrate only identify sera with anti-Ro60 reactivity. Twenty serum samples showed anti-Ro52 without anti-Ro60 and anti-SSB/La on line immunoassay. By additional testing, 2/20 sera were found positive for anti-Ro60 reactivity. The remaining 18 sera were not identified by any of the classical anti-SSA/Ro assays and were considered to be reactive only with Ro52 and not with Ro60. This anti-Ro52 reactivity was confirmed by natural and recombinant Ro52 in 16/18 cases. 12/18 sera corresponded to connective tissue diseases. <b>Conclusion:</b> Anti-Ro52 positive sera without any evidence of anti-Ro60 and anti-La/SSB reactivity can be considered as an independent group that is systematically missed by classical anti-SSA/Ro detection methods owing to a bias towards anti-Ro60 reactivity. The anti-Ro52 sera are precipitin negative, not retrieved by SSA/Ro enzyme linked immunosorbent assays (ELISAs) based on natural SSA/Ro, and show no specific ANA fluorescence staining pattern. These findings together with the clinical data indicate that anti-Ro52 should be considered as an additional and independent serum marker.
Informed Consent for Research and Authorization under the Health Insurance Portability and Accountability Act Privacy Rule: An Integrated Approach
Authors: David Shalowitz, David Wendler
Journal: Annals of Internal Medicine (2006)

Researchers have found that implementation of the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule is having a negative impact on clinical research. This impact traces, in part, to many research institutions complying with HIPAA by adding lengthy, complex language to their research consent documents. The addition of extensive language burdens institutional review boards and may undermine participants' understanding of the research in which they take part. Comparative analysis reveals, however, that the addition of lengthy text often is unnecessary. The U.S. federal requirements for informed consent for human subjects research and the HIPAA Privacy Rule's requirements for individual authorization overlap substantially. Hence, consent forms that satisfy the U.S. federal regulations for human subjects research need only minimal additional text to also satisfy the authorization requirements under the HIPAA Privacy Rule.
Pathways of fatty acid metabolism in human platelets
Authors: Phin Cohen, Arie Derksen, Hendrik van den Bosch
Journal: Journal of Clinical Investigation (1970)

The metabolic fate of 14C-labeled fatty acids which have been incubated with human platelets, has been traced. The following has been shown. (a) Intact platelets have a considerable capacity to oxidize fatty acids. (b) When tracer amounts of four of the most common fatty acids in normal plasma were incubated with platelets, each showed a distinctive pattern of uptake among neutral lipids and phospholipids. With regard to the latter, it was shown that these distribution patterns were, in most cases, similar to those of the fatty acids found in natural platelet phospholipids. (c) By increasing the time of incubation or the amount of added oleic acid, the distribution of oleic acid uptake between lecithin and other phosphoglycerides was altered so that a larger share was incorporated into the latter. (d) The effects of added lysolecithin or lysoethanolamine phosphoglycerides on oleic acid incorporation into platelet phosphoglycerides are quite variable. At low concentrations, added lysolecithin functions chiefly as a reaction partner for oleic acid. Added adenosine triphosphate and CoASH augment the incorporation of oleic acid into lecithin over a wide range of added lysolecithin (12.5-500 μmoles/liter). At higher concentrations of added lysolecithin, in the absence of ATP and CoASH, oleic acid incorporation into lecithin is considerably reduced. Also, added lysolecithin and lysoethanolamine phosphoglycerides, in the absence of ATP and CoASH, are able, at certain concentrations, to stimulate oleic acid incorporation into all except the serine phosphoglycerides. (e) Platelets appear to have a de novo pathway for renewal of lecithin.
Glutathione Transferase P1
Authors: Jiansheng Zhou, C. Roland Wolf, Colin J. Henderson, Yeping Cai, Philip G. Board, Paul S. Foster, Dianne C. Webb
Journal: American Journal of Respiratory and Critical Care Medicine (2008)

Rationale: Although epidemiological studies have linked asthma susceptibility and severity to polymorphisms in human glutathione transferase Pi (GSTP) 1, there is no direct evidence for a functional involvement of GSTP1 in processes that are pathognomic of asthma.Objectives: To examine the role of GSTP1 in modulating the development of allergic airways disease.Methods: Allergic airways disease was induced in wild-type (WT) and Gstp-null mice employing both acute and chronic models. Eosinophilia, goblet cells, and remodeling were quantified by histological assessment; respiratory function was determined using invasive methods. ELISA was used to evaluate Th2 cytokines, eotaxin, and phospho-c-Jun. Gstp1/2 expression was quantified by reverse transcriptase–polymerase chain reaction.Measurements and Main Results: Compared with allergic WT mice, eosinophilia, goblet cell hyperplasia, airway remodeling, lung resistance, and IL-5 were enhanced in allergic Gstp-null mice. However, the protective efficacy of GSTP1 was mouse-strain dependent, and associated with inherent variation in expression of Gstp1. Although elevated levels of phospho-c-Jun were detected in Gstp-null mice, treatment of WT mice with a GSTP/c-Jun N-terminal kinase (JNK) inhibitory peptide enhanced phospho-c-Jun and significantly attenuated allergic responses.Conclusions: GSTP1 attenuates the severity of allergic airways disease. However, the efficacy of GSTP1 correlated with mouse strain-dependent variation in Gstp1 expression. Although GSTP1 attenuated c-Jun phosphorylation, treatment with a GSTP/JNK inhibitory peptide revealed an inverse relationship between c-Jun phosphorylation and allergic responses, indicating that the mechanism by which GSTP attenuates allergic responses is not dependent on the JNK/c-Jun axis. Our data, together with epidemiological evidence, suggest variation in expression and/or function of this protein is an important determinant in asthma pathophysiology.
Heterogeneity of natural killer cells in the mouse.
Authors: J A Lust, V Kumar, R C Burton, S P Bartlett, M Bennett
Journal: The Journal of Experimental Medicine (1981)

Mice were treated with the bone-seeking isotope, 89Sr, cyclophosphamide, and short-term lethal irradiation in vivo, and murine spleen cells are treated with anti-Nk-1.2 plus complement (C) in vitro. Fresh spleen cell suspensions from the above groups and from beige and neonatal mice were subsequently tested for natural killer (NK) cell activity against a panel of lymphoid and nonlymphoid tumor cell target. NK cell reactivities against YAC-1, MPC-11, and Cl.18 tumors were markedly and consistently reduced in (a) mice treated with 89Sr, (b) spleen cells treated with anti-Nk-1.2 plus C, and (c) C57BL/6 bg/bg mice. In contrast, NK activities against FLD-3 and WEHI-164.1 tumors were usually normal in mice treated with 89Sr, in beige mutant mice, and in spleen cells after treatment with anti-Nk-1.2 antibody and C. It appears, therefore, that two major groups of NK cells exist in fresh mouse spleen cells suspensions. NK-A cells are marrow dependent, Nk antigen positive, and deficient in beige mice; these lyse YAC-1, MPC-11, and Cl.18 tumors. NK-B cells, which are responsible for the lysis of WEHI-164.1 and FLD-3, are Nk antigen negative, marrow independent, and unaffected by the bg/bg mutation. Other features of NK-B cells, suggest that these NK cells, although they share the characteristics mentioned above, differ among themselves especially with respect to age of maturation and susceptibility to cyclophosphamide and total body irradiation. The NK-B group may therefore induce subsets that remain to be defined.